Financing

Noncontrolling interest transactions and other

Biogen Noncontrolling interest transactions and other increased by 82.3% to $11.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 769.2%, from $1.30M to $11.30M. Over 2 years (FY 2021 to FY 2023), Noncontrolling interest transactions and other shows an upward trend with a -48.8% CAGR.

Analysis

StatementCash Flow Statement
SectionFinancing
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026
Metric ID: lin_noncontrolling_interest_transactions_and_other

Historical Data

16 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q3 '24Q1 '25Q3 '25Q1 '26
Value-$31.90M-$2.40M$0.00$4.10M$7.30M-$5.50M-$11.50M$16.50M-$16.80M$2.20M-$7.90M$7.30M-$12.60M$1.30M$6.20M$11.30M
QoQ Change+92.5%+100.0%+78.0%-175.3%-109.1%+243.5%-201.8%+113.1%-459.1%+192.4%-272.6%+110.3%+376.9%+82.3%
YoY Change+122.9%-129.2%+302.4%-330.1%+140.0%+31.3%-55.8%-672.7%-82.2%+149.2%+769.2%
Range-$31.90M$16.50M
CAGR-24.2%
Avg YoY Growth+22.3%
Median YoY Growth+31.3%
Current Streak3 quarters growth

Frequently Asked Questions

What is Biogen's noncontrolling interest transactions and other?
Biogen (BIIB) reported noncontrolling interest transactions and other of $11.30M in Q1 2026.
How has Biogen's noncontrolling interest transactions and other changed year-over-year?
Biogen's noncontrolling interest transactions and other increased by 769.2% year-over-year, from $1.30M to $11.30M.
What is the long-term trend for Biogen's noncontrolling interest transactions and other?
Over 2 years (2021 to 2023), Biogen's noncontrolling interest transactions and other has grown at a -48.8% compound annual growth rate (CAGR), from -$22.90M to -$6.00M.